Chinese scientists have built a fully autonomous robot that performs ultra-precise eye injections, cutting surgical errors and opening a new era for robotic retinal treatment.
A Breakthrough in Robotic Eye Surgery
Chinese researchers have developed a self-operating robotic system that can carry out ultra-delicate eye injections inside the confined space of the human eye, marking a major breakthrough in robotic microsurgery.
The system, designed by the Institute of Automation under the Chinese Academy of Sciences, is capable of performing both subretinal and intravascular injections without direct human control during the procedure. Its performance has been detailed in a peer-reviewed study published in the journal Science Robotics.
Eye surgery on the retina is considered one of the most complex areas of medicine. Surgeons must operate on tissue that is extremely fragile and only fractions of a millimetre thick, often while working within a very narrow, fluid-filled space at the back of the eye. Even slight hand tremors or microscopic misjudgements can affect patient outcomes.
How the Self-Operating Robot Works
The new robotic system is built around advanced 3D spatial perception algorithms, combined with ultra-precise positioning and trajectory control technology. Using real-time imaging and sensing, the robot creates an accurate 3D map of the surgical field and calculates the safest path for its needle to reach the target area inside the eye.
A robotic arm then follows this planned path with exceptional stability, adjusting its movements in response to tiny changes in the environment, such as subtle shifts in eye position or tissue movement. This level of control aims to go beyond the natural limits of human dexterity, especially when dealing with tasks that require sustained accuracy at the micron scale.
During extensive testing on eyeball models, porcine eyes and live animal eyes, the robot successfully completed subretinal and intravascular injections with 100 percent accuracy. Researchers reported that the system reduced positioning errors by nearly 80 percent compared with fully manual surgery and by 55 percent compared with surgeon-controlled robotic procedures.
Why Autonomous Eye Surgery Matters
Retinal diseases such as age-related macular degeneration, diabetic retinopathy and retinal vein occlusions often require highly targeted injections at the back of the eye. These procedures are difficult to standardise, and their success can depend heavily on the individual surgeon’s skill and experience.
By using an autonomous robotic system, hospitals could potentially achieve more consistent surgical quality, reducing the risk of complications that arise from human error or fatigue. The researchers behind the project believe that this technology could raise the baseline level of safety and precision for complex eye procedures, rather than reserving the best outcomes only for patients treated by a small number of top specialists.
Another advantage is training time. It can take many years for ophthalmic surgeons to master intricate retinal techniques. A reliable robotic platform could shorten the learning curve, allowing younger doctors to perform advanced procedures with robotic assistance while they build experience.
Potential Impact on Patients and Remote Hospitals
One of the most promising aspects of the new system is its potential use in remote or underserved regions, where specialist eye surgeons are scarce or unavailable. In the future, an autonomous or semi-autonomous robot could be operated under remote supervision from a major eye centre, bringing advanced retinal treatments closer to patients who currently have to travel long distances or go without care.
If successfully translated to human use, the technology could also expand access to complex procedures that are currently limited to high-end hospitals in large cities. In countries with ageing populations and rising rates of diabetes, that shift could help prevent avoidable blindness on a much larger scale.
For individual patients, the benefits could include more predictable results, shorter procedure times and fewer repeat interventions if injections are delivered more precisely to their intended targets inside the eye.
What Comes Next for Robotic Microsurgery
While the animal trials show strong promise, the autonomous eye surgery robot will still need to go through further testing, regulatory review and careful adaptation before it can be used in human patients. Questions around safety, redundant fail-safes, surgeon oversight and ethical guidelines will all need to be answered.
Experts say that even when deployed in clinical settings, the goal is unlikely to be replacing human surgeons entirely. Instead, the robot is expected to function as a highly specialised tool that works under a doctor’s supervision, handling the most delicate parts of the procedure while the surgeon focuses on planning, decision-making and overall care.
Still, the work carried out by the Chinese research team is widely seen as a major step forward for robotic microsurgery. If the technology matures as expected, it could help set a new global benchmark for precision eye surgery and transform the way sight-threatening retinal diseases are treated in the years ahead.
